Tuesday, January 21, 2025
spot_img

Rubicon Organics Grants RSUs and PSUs

VANCOUVER, British Columbia, Jan. 20, 2025 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, announces that it has granted 784,712 restricted share units (“RSUs”) and 784,712 performance share units (“PSUs”).

RSU Grant

The Company has awarded a total of 784,712 RSUs under its Omnibus Equity Incentive Plan to selected executives and employees. The RSUs will vest over a period ranging from one to three years from the grant date. Upon vesting, each RSU grants the holder the right to receive one common share of the Company, or, at the discretion of the Company’s Board of Directors, may be settled in cash.

PSU Grant

The Company has granted a total of 784,712 PSUs under its Omnibus Equity Incentive Plan to certain executives and employees. These PSUs will vest after three years, contingent on the achievement of specific performance targets. If the performance conditions are met, each vested PSU entitles the holder to receive one common share of the Company, or, at the discretion of the Company’s Board of Directors, may be settled in cash.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co.™, its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.

The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: [email protected]

The TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws including, but not limited to, statements regarding the vesting conditions, timing, and settlement of the RSUs and PSUs granted by the Company. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances. Risks and uncertainties associated with the forward looking information in this press release include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits for construction at its facilities in a timely manner; regulatory or political change such as changes in applicable laws and regulations, including bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; Rubicon Organics’ limited operating history and lack of historical profits; reliance on management; the effect of capital market conditions and other factors on capital availability; the Company’s ability to attract and retain skilled staff; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Powered by SlickText.com

Hot this week

CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES

Bid date, 2025-01-21Auction date2025-01-21Settlement date2025-01-22Maturity Date2025-01-29Nominal amount790 billion SEKInterest...

Form 8.5 (EPT/RI) – De La Rue plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Form 8.5 (EPT/RI) – Alliance Pharma plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Topics

CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES

Bid date, 2025-01-21Auction date2025-01-21Settlement date2025-01-22Maturity Date2025-01-29Nominal amount790 billion SEKInterest...

Form 8.5 (EPT/RI) – De La Rue plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Form 8.5 (EPT/RI) – Alliance Pharma plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY...

Changes in the number of own shares held by Aktia Bank Plc

Aktia Bank PlcStock Exchange Release 21 January 2025 at 10.00...

Municipality Finance issues USD 300 million benchmark under its MTN programme

Municipality Finance PlcStock exchange release 21 January 2025 at...

Serstech receives 3.6 MSEK order from its partner Kaiser

Serstech has today received an order from its partner...
spot_img

Related Articles

Popular Categories

spot_img